{
  "docId": "019dd923-622c-750b-8b9a-3bcd52c6e583",
  "docSlug": "f06b0b5d2079",
  "documentTitle": "Soleno Therapeutics (SLNO)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Scorpion Capital",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2025-08-15 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 177,
  "pageCount": 415,
  "prevPage": 176,
  "nextPage": 178,
  "slideType": "testimonial",
  "function": "illustrate_case",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide uses anecdotal evidence from Facebook groups to highlight patient dissatisfaction and side effects.",
  "elementsJson": [
    "paragraph",
    "screenshot",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-3bcd52c6e583/177",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-3bcd52c6e583",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-3bcd52c6e583.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-3bcd52c6e583#slide-177",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Not surprisingly, posts are already piling up with parents indicating they have discontinued the drug or considering it",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-64ce-7561-b2a5-65d93197e0f2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.86,
        "x": 0.07,
        "y": 0.45
      },
      "kind": "image",
      "text": "Collage of Facebook group posts",
      "attrs": null,
      "subkind": "screenshot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9f312f2a-4f3c-457b-92a4-865faf087a6a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.86,
        "x": 0.07,
        "y": 0.07
      },
      "kind": "paragraph",
      "text": "Not surprisingly, posts are already piling up with parents indicating they have discontinued the drug or considering it: “we have been on Vykat 5 weeks...we tried titrating up but behavior was worse...I am so tempted to just quit”; “has anyone stopped taking this medication? We are seriously considering it...it’s week 3 for us and she’s still chewing pills...it’s just not working...I’m noticing swelling in her ankles and some hair growth...the cons are outweighing the pros for us at this point”; “we had to discontinue but have our eyes on the Hero study and pray it is approved”; “we just opted out of Vykat for several reasons...”; “we are officially out of the trial now...the effect on hyperphagia was minimal...”",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "833c9de4-3a32-47e2-83e3-4a21ee6294f4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "“we have been on Vykat 5 weeks...we tried titrating up but behavior was worse...I am so tempted to just quit”; “has anyone stopped taking this medication? We are seriously considering it...it’s week 3 for us and she’s still chewing pills...it’s just not working...I’m noticing swelling in her ankles and some hair growth...the cons are outweighing the pros for us at this point”; “we had to discontinue but have our eyes on the Hero study and pray it is approved”; “we just opted out of Vykat for several reasons...”; “we are officially out of the trial now...the effect on hyperphagia was minimal...” — Facebook users in Vykat discussion groups.",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-64ce-7561-b2a5-69aed4bbe21d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.75,
        "x": 0.07,
        "y": 0.91
      },
      "kind": "source-note",
      "text": "Source: Facebook groups - “Vykat discussion group” https://www.facebook.com/share/g/17JomVRpoV/?mibextid=wwXlfr; “Vykat for PWS: Evidence, Experience, & Encouragement” https://www.facebook.com/share/g/14HMwkfXhzm/?mibextid=wwXlfr",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4cfcbe1f-7663-4a57-8aa2-a8b26eb327bc",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}